Biopep Solutions Inc. is advancing innovative therapeutics in the field of oncology. Help us move our cancer research forward.
The current offering is an RRSP Eligible Investment + Investors May Apply to Receive 30% in B.C. Tax Credit.
- We are looking to raise $5 Million to advance our cancer drug to the human trial testing stage
- We are selling common shares at $0.75 per share and the deadline has been extended to March 1, 2018
- We are in the last stage of pre-clinical testing
- Plans for testing in cancer patients are being finalized at the BC Cancer Agency
- Our drug demonstrates competative advantages over current therapies
- Strong Scientific Advisory Board with qualified Management Team
- Certified by the BC Govt as an Eligible Business Corporation
- We hold patented Intellectual Property
01 You invest $5,000 or more in Biopep Solutions Inc.
02 Biopep Solutions Inc. uses your investment to further develop its novel anti-cancer drug, BPS-001, advancing it to the human trial testing stage.
03 You place the proceeds into a self-administered RRSP designated account and potentially reduce your net cost* and reduce your tax payable.
04 Apply to receive a 30% B.C. tax credit under the Small Business Venture Capital Act.
*Tax reduction from a contribution to an RRSP differs for individuals with different levels of taxable income. Please see your financial advisor to estimate your tax scenario and risk factor(s).